Graded peak cycle ergometer test for cognitively impaired patients with Parkinson's disease: a pilot study

被引:1
|
作者
Hurlimann, Andre [1 ]
Pastore-Wapp, Manuela [1 ,2 ]
van Beek, Judith [1 ]
Hirsch, Mark A. [3 ]
van Wegen, Erwin E. H. [4 ]
Vanbellingen, Tim [1 ,2 ]
机构
[1] Luzerner Kantonsspital, Neuroctr, Spitalstr, CH-6000 Luzern, Switzerland
[2] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland
[3] Carolinas Med Ctr, Dept Phys Med & Rehabil, Carolinas Rehabil, Charlotte, NC 28203 USA
[4] Amsterdam UMC, Dept Rehabil Med, VUmc, Amstardam, Netherlands
关键词
Bicycle ergometry test; cognitive symptom; heart rate; Parkinson disease; TREADMILL EXERCISE TESTS; CARDIOVASCULAR-RESPONSES; HEART-RATE;
D O I
10.1080/09593985.2022.2034078
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background Cognitive decline affects up to 50% of patients with Parkinson's disease (PD) in the course of the disease and may be amenable to exercise interventions. To accurately set adequate training intensities, standardized exercise testing is required but such testing takes considerable time and effort. The aim of this pilot study was to investigate the feasibility of a graded peak cycle ergometer exercise test in cognitively impaired patients with Parkinson's Disease (PD), and to define whether age-predicted maximal heart rate (HRmax) matched measured HRmax. Methods A convenience sample of seven patients with PD (Hoehn and Yahr: 2-4, and cognitive impairment (Montreal Cognitive Assessment (MoCA) <= 26) completed a graded peak cycle ergometer test to voluntary exhaustion. Borg Rating of Perceived Exertion was used to record the individual's perception of exertion. Pre-defined age-predicted HRmax (calculated as 208-(0.7 x age) was compared with the measured HRmax using Bland-Altman plot and a two-one-sided test. Results All PD patients completed the graded exercise test between 8-12 minutes, showing therefore 100% compliance to the test protocol. No adverse events occurred. Predicted HRmax and measured HRmax did not differ. Conclusion We demonstrate feasibility of graded peak cycle ergometer testing in PD patients with cognitive impairment. The good correspondence of age-predicted HRmax equation with measured HRmax, in this small sample, may in the future provide clinicians with a tool to define training intensities in cognitively impaired PD, without cardiac disease. However, further research is needed to confirm these results.
引用
收藏
页码:1249 / 1256
页数:8
相关论文
共 50 条
  • [1] Cortical atrophy in cognitively impaired Parkinson's disease patients
    Almuqbel, M. M.
    Melzer, T. R.
    Myall, D. J.
    MacAskill, M. R.
    Livingston, L.
    Wood, K.
    Pitcher, T. L.
    Keenan, R. J.
    Dalrymple-Alford, J. C.
    Andrson, T. J.
    MOVEMENT DISORDERS, 2016, 31 : S397 - S397
  • [2] Clinical EEG in cognitively impaired patients with Parkinson's Disease
    Schlede, Nina
    Zimmermann, Ronan
    Ehrensperger, Michael M.
    Gschwandtner, Ute
    Hardmeier, Martin
    Hatz, Florian
    Monsch, Andreas U.
    Naegelin, Yvonne
    Fuhr, Peter
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 75 - 78
  • [3] Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
    Rektorova, Irena
    Biundo, Roberta
    Marecek, Radek
    Weis, Luca
    Aarsland, Dag
    Antonini, Angelo
    PLOS ONE, 2014, 9 (01):
  • [4] To rise and to fall: functional connectivity in cognitively normal and cognitively impaired patients with Parkinson's disease
    Gorges, Martin
    Mueller, Hans-Peter
    Lule, Dorothee
    Pinkhardt, Elmar H.
    Ludolph, Albert C.
    Kassubek, Jan
    NEUROBIOLOGY OF AGING, 2015, 36 (04) : 1727 - 1735
  • [5] Decisional capacity in cognitively impaired patients with Parkinson disease
    Marson, Daniel C.
    Hershey, Linda A.
    NEUROLOGY, 2013, 81 (09) : 780 - 781
  • [6] Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease
    Dymek, MP
    Atchison, P
    Harrell, L
    Marson, DC
    NEUROLOGY, 2001, 56 (01) : 17 - 24
  • [7] Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease -: A rCBF scintigraphy study
    Wallin, A.
    Ekberg, S.
    Lind, K.
    Milos, V.
    Granerus, A. -K.
    Granerus, G.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (06): : 347 - 354
  • [8] Grey matter atrophy in cognitively impaired Parkinson's disease
    Melzer, Tracy R.
    Watts, Richard
    MacAskill, Michael R.
    Pitcher, Toni L.
    Livingston, Leslie
    Keenan, Ross J.
    Dalrymple-Alford, John C.
    Anderson, Tim J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (02): : 188 - 194
  • [9] Efficacy of pallidotomy and thalamotomy in cognitively impaired Parkinson disease patients
    Wheelock, VL
    King, DS
    Levine, DK
    Duke, CM
    Yu, JT
    Na-Lee, CK
    Pappas, CTE
    Sigvardt, KA
    NEUROLOGY, 2001, 56 (08) : A277 - A278
  • [10] Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease - Reply
    Marson, D
    Dymek, M
    Karlawish, J
    NEUROLOGY, 2001, 56 (12) : 1782 - 1783